Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer

Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer
Seattle, Washington (PRWEB) April 16, 2015 Dana-Farber Cancer Institute and its Belfer Institute for Applied Cancer Science and Resolution Bioscience, Inc. today announced the successful completion of a collaborative agreement to co-develop a novel, blood-based, clinic ready, Next Generation Sequencing (NGS) assay for non-small cell lung cancer (NSCLC). The collaboration is the first to demonstrate ...

Citizen Science In The Peruvian Amazon Presentation On January 14 At 6:30 pm In The BioScience Health Center On The Iowa Central Community College Campus In Fort Dodge, IA

Citizen Science In The Peruvian Amazon Presentation On January 14 At 6:30 pm In The BioScience Health Center On The Iowa Central Community College Campus In Fort Dodge, IA
Fort Dodge, IA (PRWEB) January 08, 2015 The Citizen Science in the Peruvian Amazon is a free presentation that will be an eye opening experience for teachers, students and the general public. Everyone is invited to attend the presentation that will be held on the Iowa Central Community College campus in the BioScience Health Center ...

Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs

Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs
Ottawa, Ontario (PRWEB) November 27, 2014 Spartan Bioscience today announced that it has received South Korean Ministry of Food and Drug Safety (MFDS) regulatory approval for its Spartan RX CYP2C19 System. The system provides genetic results in less than 60 minutes from a non-invasive cheek swab. The automated system is indicated as an aid ...

Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs

Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs
Ottawa, Ontario (PRWEB) November 27, 2014 Spartan Bioscience today announced that it has received South Korean Ministry of Food and Drug Safety (MFDS) regulatory approval for its Spartan RX CYP2C19 System. The system provides genetic results in less than 60 minutes from a non-invasive cheek swab. The automated system is indicated as an aid ...